Ultragenyx Pharmaceutical (RARE) EBITDA Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,961.00 |
| Dec 31, 2025 | 5,220.00 |
| Sep 30, 2025 | -4,205.00 |
| Jun 30, 2025 | 3,808.00 |
| Mar 31, 2025 | -2,859.00 |
| Dec 31, 2024 | 2,034.00 |
| Sep 30, 2024 | -1,548.00 |
| Jun 30, 2024 | 7,278.00 |
| Mar 31, 2024 | -5,610.00 |
| Dec 31, 2023 | 5,215.00 |
| Sep 30, 2023 | -1,137.00 |
| Jun 30, 2023 | 1,674.00 |
| Mar 31, 2023 | -1,243.00 |
| Dec 31, 2022 | 10,722.00 |
| Sep 30, 2022 | -8,965.00 |
| Jun 30, 2022 | 1,245.00 |
| Mar 31, 2022 | -4,793.00 |
| Dec 31, 2021 | -1,297.00 |
| Sep 30, 2021 | -1,485.00 |
| Jun 30, 2021 | 1,205.00 |
| Mar 31, 2021 | -226.00 |
| Dec 31, 2020 | -4,320.00 |
| Sep 30, 2020 | 4,042.00 |
| Jun 30, 2020 | 23,015.00 |
| Mar 31, 2020 | -6,696.00 |
| Dec 31, 2019 | 19,213.00 |
| Sep 30, 2019 | 826.00 |
| Jun 30, 2019 | 8,022.00 |
| Mar 31, 2019 | 959.00 |
| Dec 31, 2018 | 20,654.00 |
| Sep 30, 2018 | -2,035.00 |
| Jun 30, 2018 | 16,194.00 |
| Mar 31, 2018 | 370,745.00 |
| Dec 31, 2017 | 3.77 Mn |
| Dec 31, 2016 | -135.17 Mn |
| Sep 30, 2016 | 28.22 Mn |